
Ricola Original and Mixed Berry Lozenges
Allegations: Falsely marketing that the herb ingredients pictured on the front labels provide the advertised therapeutic benefits
Wilmot et al. v. Ricola USA, Inc.
23-cv-1709, M.D. Fla.
(Sept. 2023)
Ricola Nasal Care Lozenges
Misleadingly marketing that lozenges are “Nasal Care” products that “cool[] passage[s]” and “sooth[] nose[s]” when the active ingredient (menthol) does not relieve nasal symptoms and the product does not contain any nasal decongestant active ingredients
Misleadingly marketing lozenges as “Max Strength” when they provide less menthol per drop than the FDA allows and there’s no scientific evidence showing that the amount of menthol in the product provides more therapeutic benefit than products with less menthol
Pending
Allegations: Falsely marketing that the herb ingredients pictured on the front labels provide the advertised therapeutic benefits
Allegations: Misleadingly marketing products as if green tea and echinacea flower are active ingredients when the back label discloses both are inactive ingredients and menthol is the active ingredient that…
Allegations: False natural claims
Allegations: Misleadingly representing that the therapeutic effect of the cough drops comes from herbs when none of the herbs are active ingredients
January 2016: The lawsuit was dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.. The reasons for the dismissal have not yet…
Company misleadingly markets lozenges as an effective nasal decongestant, according to lawsuit.